Ergomed PLC
LSE:ERGO

Watchlist Manager
Ergomed PLC Logo
Ergomed PLC
LSE:ERGO
Watchlist
Price: 1 346 GBX Market Closed
Market Cap: 701.1m GBX
Have any thoughts about
Ergomed PLC?
Write Note

Wall Street
Price Targets

ERGO Price Targets Summary
Ergomed PLC

There are no price targets for ERGO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ergomed PLC Competitors:
Price Targets
ABCL
Abcellera Biologics Inc
325% Upside
BIO
Bio Rad Laboratories Inc
23% Upside
TEM
Tempus AI Inc
75% Upside
MLC
Malin Corporation PLC
83% Upside
688222
HitGen Inc
21% Upside
NEO
Neogenomics Inc
23% Upside
MCAP
MedCap AB (publ)
8% Downside
BIOT
Biotage AB
40% Upside

Revenue
Forecast

Revenue Estimate
Ergomed PLC

For the last 8 years the compound annual growth rate for Ergomed PLC's revenue is 27%. The projected CAGR for the next 3 years is 11%.

27%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ergomed PLC

For the last 8 years the compound annual growth rate for Ergomed PLC's operating income is 40%. The projected CAGR for the next 3 years is 22%.

40%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Ergomed PLC

For the last 8 years the compound annual growth rate for Ergomed PLC's net income is 50%. The projected CAGR for the next 3 years is 26%.

50%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-29%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ERGO's stock price target?
Not Available

ERGO doesn't have any price targets made by Wall Street professionals.

What is Ergomed PLC's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Ergomed PLC's revenue is 27%. The projected CAGR for the next 3 years is 11%.

What is Ergomed PLC's Operating Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Ergomed PLC's operating income is 40%. The projected CAGR for the next 3 years is 22%.

What is Ergomed PLC's Net Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Ergomed PLC's net income is 50%. The projected CAGR for the next 3 years is 26%.

Back to Top